1-3 of 3
Kate Stumpo, BA
Close
Sort by
Journal Articles

A Phase (ph) 1b/2 Study of TAK-659, an Investigational Dual FLT-3 and SYK Inhibitor, in Patients (Pts) with Relapsed or Refractory Acute Myelogenous Leukemia (R/R AML)

Keith Pratz, MD, Mark J. Levis, MD, John C Morris, MD, Trisha Wise-Draper, MD PhD, Moshe Levy, MD, Dale L. Bixby, Patrick Burke, MD, Daniela Hernandez, MD, Kate Stumpo, BA, Karuppiah Kannan, Emily Sheldon-Waniga, PhD, Shining Wang, MD, Steven Zhang, PhD, Yaping Shou, MD PhD, Jessica K. Altman, MD, Jason Kaplan, MD, Olga Frankfurt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2622.
https://doi.org/10.1182/blood.V130.Suppl_1.2622.2622
Published: 2017
Journal Articles

Phase 1 Study of TAK-659, an Investigational Reversible Dual SYK/FLT-3 Inhibitor, in Patients (Pts) with Lymphoma: Updated Results from Dose-Escalation and Expansion Cohorts

Jason Kaplan, MD, Leo I. Gordon, MD, Alessandro Rambaldi, MD Prof, Giuseppe Gritti, MD, Rakesh Popat, MD PhD, Howard A. Burris, MD, Manish R Patel, MD, Sumit Madan, MD, Ian Chau, MD, John A. Radford, MD, Swami P. Iyer, MD, Jaime Perez De Oteyza, MD, Pier Luigi Zinzani, MD, Shining Wang, MD, Emily Sheldon-Waniga, PhD, Kate Stumpo, BA, Yaping Shou, MD PhD, Cecilia Carpio, MD, Francesc Bosch, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1554.
https://doi.org/10.1182/blood.V130.Suppl_1.1554.1554
Published: 2017
Journal Articles

Updated Results from a Phase 1 Study of TAK-659, an Investigational and Reversible SYK Inhibitor, in Patients (Pts) with Advanced Solid Tumor or Lymphoma Malignancies

Jason B Kaplan, MD, Leo I Gordon, MD, Jeffrey R Infante, MD, Rakesh Popat, MD PhD, Alessandro Rambaldi, MD, Sumit Madan, MD, Manish R. Patel, MD, Giuseppe Gritti, MD, Chin-Hin Ng, MD FRCPATH, Ian Chau, MD, John A Radford, MBChB, MRCP, MD FRCP, Jaime Perez de Oteyza, MD PhD, Pier Luigi Zinzani, MD PhD, Stephanie Faucette, PharmD, PhD, Emily Sheldon-Waniga, PhD, Miguel Williams, BA, Kate Stumpo, BA, Yaping Shou, MD PhD, Cecilia Carpio, MD, Francesc Bosch, MD PhD
Journal: Blood
Blood (2016) 128 (22): 624.
https://doi.org/10.1182/blood.V128.22.624.624
Published: 2016